INSIGHTS ON DRUG DEVELOPMENT

• Target Product Profiles And Phase 1 Clinical Plans: Laying The Groundwork For Success

  By integrating scientific rigor, regulatory foresight, and market awareness into early-stage planning, companies can leverage a robust TPP to optimize decision-making and development.

• Closing The QC Gap For mAbs: Rapid Answers Without Compromising

  Monoclonal antibodies are complex biologics requiring precise analytical strategies to monitor critical quality attributes and impurities, with molecular assays like qPCR supporting sensitive detection, product integrity, and regulatory compliance.

• ITC For Binding Characterization In Pharmaceutical Research

  Discover an Isothermal Titration Calorimetry tool that is precise for characterizing molecular interactions, which is crucial for drug discovery and lead optimization in pharmaceutical research.

• Fast And Efficient Processing Of ELISA Assays

  Explore how a streamlined ELISA workflow using automated washing and reading tools enabled accurate detection of hepatitis B markers with no false results.

• Glucagon-Like Peptide-1 (GLP-1) Analogues Applications Notebook

  12/11/2025

  View this collection of application notes about the chromatographic analysis and purification of GLP-1 analogues, including Semaglutide, Tirzepatide, Liraglutide, and Exenatide.

• Cell Cycle Mapping In Tumors With Advanced Technologies

  9/2/2025

  Discover how spatial profiling and advanced imaging tools are transforming drug discovery, featuring Wayne Stallaert’s lab’s work on cell cycle mapping and biomarker insights in cancer research.

• Ask Us Anything: Eric Fang On New Challenges In Pharma Development

  7/24/2026

  Eric Fang on meeting new pharmaceutical development challenges with a two-part investment — technology that answers R&D questions faster, and scientists given the support to tackle what technology can't.

• Cost And Scalability Key Drivers Of Expanded Gene Therapy Access

  5/16/2025

  Gene therapies are expanding beyond rare diseases, but high costs hinder access. Discover how innovations in viral vector manufacturing could make these breakthroughs more affordable.

• Simplify And Streamline Method Development With In Silico Modeling

  5/19/2026

  Automated screening paired with in silico modeling can cut method development time while improving robustness. See how combining experimentation and simulation enables faster decision‑making.